Glimfra MV 1 Tablet ER

What is Glimfra MV 1 Tablet ER?

Glimfra MV 1 Tablet ER contains a combination of Glimepiride, Metformin, and Voglibose. It is prescribed for the treatment of type 2 diabetes mellitus (DM). This medication helps to manage blood glucose levels by increasing insulin release from the pancreas, reducing glucose production in the liver, and lowering postprandial glucose levels.

What are the possible side effects of Glimfra MV 1 Tablet ER?

Common side effects associated with Glimfra MV 1 Tablet ER include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infections.

Are there any specific conditions in which Glimfra MV 1 Tablet ER should not be taken?

Glimfra MV 1 Tablet ER should not be used if you have a known allergy to any of its components or excipients. It is also contraindicated for patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis including diabetic ketoacidosis.

Is it safe to take alcohol while I am also taking Glimfra MV 1 Tablet ER?

No, Glimfra MV 1 Tablet ER should not be taken with alcohol. Alcohol consumption may lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.

Can the use of Glimfra MV 1 Tablet ER cause hypoglycemia?

Yes, Glimfra MV 1 Tablet ER can cause hypoglycemia. This can occur if you miss meals, drink alcohol, over-exercise, or take other antidiabetic medications simultaneously. Regular blood sugar monitoring is essential to manage this potential side effect.

What are the instructions for the storage and disposal of Glimfra MV 1 Tablet ER?

Store Glimfra MV 1 Tablet ER in its original container, sealed tightly. Follow the instructions provided on the medication label regarding storage and expiry date. Dispose of unused medication properly to prevent contamination by pets or unauthorized individuals.